Shares of other companies:
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Tesla Q1: Model 2 Could Be Their Model T
April 25, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
BSX Stock News and Mentions of Boston Scientific Corp. Stocktwits
Updated: April 29, 2024 (10:08)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Boston Scientific Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Boston Scientific Corp. (BSX).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Boston Scientific stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Boston Scientific Corp. (BSX)
April 29, 2024 (13:40) / "Zacks Commentary" (by Zacks Equity Research)
Is Boston Scientific ( BSX ) Outperforming Other Medical Stocks This Year?
Here is how Boston Scientific (BSX) and Canopy Growth Corporation (CGC) have performed compared to their sector so far this year.
In Article Trend: Somewhat-Bullish
April 29, 2024 (11:20) / "Zacks Commentary" (by Zacks Investment Research)
The Zacks Analyst Blog Highlights 10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp
10x Genomics, Cardinal Health, Hologic, Boston Scientific and LabCorp are included in this Analyst Blog.
In Article Trend: Neutral
April 26, 2024 (15:34) / "Investors Business Daily" (by Investor's Business Daily)
Stocks Rebound Amid Big-Cap Earnings: Weekly Review
Stock Market Rebounds. Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review Investor's Business Daily ...
In Article Trend: Neutral
April 26, 2024 (15:30) / "Zacks Commentary" (by Urmimala Biswas)
3 Medical Products Stocks Set to Beat This Earnings Season
Here are three stocks, TXG, CAH and HOLX, which are expected to beat earnings estimates in the ongoing reporting cycle.
In Article Trend: Neutral
April 26, 2024 (13:50) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why Boston Scientific ( BSX ) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
In Article Trend: Bullish
April 26, 2024 (12:09) / "Benzinga" (by Avi Kapoor)
Top 4 Health Care Stocks That May Plunge This Month - AstraZeneca ( NASDAQ:AZN ) , Boston Scientific ( NYSE:BSX )
As of April 26, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when ...
In Article Trend: Bullish
April 26, 2024 (10:46) / "Investors Business Daily" (by Investor's Business Daily)
Pfizer Now Rivals The World's Most Expensive Medicine
Pfizer Stock: Pharma Giant Takes On Hemgenix, The World's Most Expensive Drug Investor's Business Daily ...
In Article Trend: Neutral
April 26, 2024 (07:00) / "Investors Business Daily" (by Investor's Business Daily)
Edwards Lifesciences Clears Technical Benchmark, Hitting 80-Plus RS Rating
When considering what names to put on your watch list, focus on stocks with an 80 or higher RS Rating. Edwards Lifesciences ( EW ) just cleared that benchmark with an upgrade from 77 to 82. X IBD's unique rating measures price movement with a 1 ( worst ) to 99 ( best ) score.
In Article Trend: Somewhat-Bullish
April 26, 2024 (07:00) / "Investors Business Daily" (by Investor's Business Daily)
Align Technology Hits 80-Plus Relative Strength Rating Benchmark
On Friday, Align Technology ( ALGN ) hit an important technical milestone, with its Relative Strength ( RS ) Rating moving into the 80-plus percentile with an upgrade to 81, up from 68 the day before. X This exclusive rating from Investor's Business Daily identifies market leadership with a 1 ...
In Article Trend: Somewhat-Bullish
April 25, 2024 (19:43) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)
Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating
Staar Surgical ( STAA ) stock had its Relative Strength ( RS ) Rating upgraded from 80 to 84 Thursday. This unique rating identifies technical performance by using a 1 ( worst ) to 99 ( best ) score that identifies how a stock's price action over the last 52 weeks matches up against other ...
In Article Trend: Somewhat-Bullish
April 25, 2024 (18:30) / "Benzinga" (by Benzinga Insights)
( BSX ) - Analyzing Boston Scientific's Short Interest - Boston Scientific ( NYSE:BSX )
Boston Scientific's BSX short percent of float has risen 8.97% since its last report. The company recently reported that it has 12.43 million shares sold short, which is 0.85% of all regular shares that are available for trading.
In Article Trend: Somewhat-Bullish
April 25, 2024 (13:45) / "Zacks Commentary" (by Zacks Equity Research)
Why Boston Scientific ( BSX ) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
In Article Trend: Bullish
April 25, 2024 (11:31) / "Investors Business Daily" (by Investor's Business Daily)
AstraZeneca, Sanofi Jump On First-Quarter Earnings; Bristol Myers Lags
AstraZeneca, Sanofi Jump On First-Quarter Earnings. Bristol Myers Lags Investor's Business Daily ...
In Article Trend: Somewhat-Bullish
April 25, 2024 (07:00) / "Investors Business Daily" (by Investor's Business Daily)
Stocks To Watch: Boston Scientific Sees Relative Strength Rating Jump To 91
On Thursday, Boston Scientific ( BSX ) received an upgrade to its Relative Strength ( RS ) Rating, from 88 to 91. X This proprietary rating measures market leadership by using a 1 ( worst ) to 99 ( best ) score that indicates how a stock's price action over the last 52 weeks matches up ...
In Article Trend: Somewhat-Bullish
April 25, 2024 (07:00) / "Investors Business Daily" (by Investor's Business Daily)
Staar Surgical Shows Market Leadership With Jump To 84 RS Rating
Staar Surgical ( STAA ) had its Relative Strength ( RS ) Rating upgraded from 80 to 84 Thursday. X This unique rating identifies technical performance by using a 1 ( worst ) to 99 ( best ) score that identifies how a stock's price action over the last 52 weeks matches up against other ...
In Article Trend: Somewhat-Bullish
April 24, 2024 (22:47) / "Investing News Network" (by Investing News Network)
Investing in Cardiovascular MedTech Companies
Efforts to address the core risk factors associated with cardiovascular diseases are coinciding with recent innovations in medical technology, which have been critical in not only preventing and managing them but also increasing the survival rate.
In Article Trend: Bullish
April 24, 2024 (17:02) / "Investors Business Daily" (by Investor's Business Daily)
IBD Stock Of The Day Flirts With Breakout On Earnings Upheaval
Medpace Stock Flirts With Breakout On Big Earnings Reversal Investor's Business Daily ...
In Article Trend: Somewhat-Bullish
April 24, 2024 (16:42) / "Benzinga" (by Vandana Singh)
Why Is Boston Scientific Stock Trading Higher On Wednesday? - Boston Scientific ( NYSE:BSX )
Boston Scientific Corporation BSX shares are trading higher on Wednesday after the company reported better-than-expected first-quarter earnings and issued guidance. The company generated first-quarter revenues of $3.86 billion, beating the consensus estimate of $3.69 billion.
In Article Trend: Somewhat-Bullish
April 24, 2024 (16:40) / "Zacks Commentary" (by Zacks Equity Research)
Boston Scientific ( BSX ) Q1 Earnings Beat Estimates, View Raised
Barring Neuromodulation, organic and operational revenues at Boston Scientific's (BSX) core business segments rise in the first quarter.
In Article Trend: Somewhat-Bullish
April 24, 2024 (16:04) / "Benzinga" (by Zacks)
Boston Scientific Q1 Earnings and Revenues Top Estimates - Boston Scientific ( NYSE:BSX ) , BioLife Solns ( NASDAQ:BLFS )
Boston Scientific BSX came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.47 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of ...
In Article Trend: Somewhat-Bullish
April 24, 2024 (15:40) / "Zacks Commentary" (by Zacks Equity Research)
AHCO vs. BSX: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both AdaptHealth Corp. ( AHCO Quick QuoteAHCO - ) and Boston Scientific ( BSX Quick QuoteBSX - ) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
In Article Trend: Bullish
April 24, 2024 (14:15) / "Benzinga" (by Globe Newswire)
Electrotherapy System Market size worth $ 1587.04 Billion, Globally, by 2031 at 4.39% CAGR - Report By Verified Market Research®
Jersey City, New Jersey, April 24, 2024 ( GLOBE NEWSWIRE ) -- The Global Electrotherapy System Market is projected to grow at a CAGR of 4.39% from 2024 to 2031, according to a new report published by Verified Market Research®.
In Article Trend: Somewhat-Bullish
April 24, 2024 (11:40) / "Zacks Commentary" (by Zacks Equity Research)
Boston Scientific ( BSX ) Q1 Earnings and Revenues Top Estimates
Boston Scientific (BSX) delivered earnings and revenue surprises of 9.80% and 4.85%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend: Neutral
April 24, 2024 (11:11) / "Investors Business Daily" (by Investor's Business Daily)
Boston Scientific Pops Into Buy Zones On Solid First-Quarter Report
Boston Scientific ( BSX ) stock advanced early Wednesday after the medical technology company reported adjusted earnings of 56 per share on $3.86 billion in first-quarter sales. On average, analysts polled by FactSet expected the company to earn 51 cents a share on $3.68 billion in sales.
In Article Trend: Bullish
April 24, 2024 (10:37) / "Benzinga" (by Shanthi Rexaline)
Nasdaq, S&P 500 To Open Higher After Tesla, TI Earnings: What's Driving Stock Futures? - Invesco QQQ Trust, Series 1 ( NASDAQ:QQQ ) , SPDR S&P 500 ( ARCA:SPY )
Nasdaq and S&P 500 futures signaled a higher open on Wednesday, thanks to upbeat guidance from EV giant Tesla, Inc. TSLA and semiconductor major Texas Instruments, Inc. TXN, although Dow futures were marginally lower.
In Article Trend: Neutral
April 24, 2024 (07:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)
Stocks To Watch: Tandem Diabetes Care Sees Relative Strength Rating Rise To 92
Tandem Diabetes Care ( TNDM ) had its Relative Strength ( RS ) Rating upgraded from 86 to 92 Wednesday. X IBD's proprietary rating tracks share price performance with a 1 ( worst ) to 99 ( best ) score. The rating shows how a stock's price behavior over the last 52 weeks compares to all the ...
In Article Trend: Bullish
April 24, 2024 (07:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)
Establishment Labs Hldgs Shows Improved Relative Strength; Still Shy Of Benchmark
Establishment Labs Hldgs Shows Improved Relative Strength. Still Shy Of Benchmark Investor's Business Daily ...
In Article Trend: Bullish
April 23, 2024 (15:36) / "Zacks Commentary" (by Zacks Equity Research)
What's in Store for These 4 Medical Products Stocks in Q1 Earnings?
Medical Products companies' quarterly results are likely to reflect a year-over-year decline in earnings. Let's see how BSX, TMO, ALGN and ICLR fare this time.
In Article Trend: Somewhat-Bullish
April 23, 2024 (07:00) / "Investors Business Daily" (by Investor's Business Daily)
Boston Scientific Gets IBD Stock Rating Upgrade
The IBD SmartSelect Composite Rating for Boston Scientific ( BSX ) rose from 94 to 96 Tuesday. X The new score means the company is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria.
In Article Trend: Bullish
April 21, 2024 (21:45) / "Benzinga" (by Shanthi Rexaline)
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week - Invesco QQQ Trust, Series 1 ( NASDAQ:QQQ ) , SPDR S&P 500 ( ARCA:SPY )
As the market runs into rough weather, the importance of the upcoming week's earnings cannot be emphasized enough. A lot is riding on the earnings reports of companies like Tesla, Inc. TSLA, Meta Platforms, Inc. META, Microsoft Corp. MSFT and Alphabet, Inc. GOOGL ( GOOG ) .
In Article Trend: Neutral
April 19, 2024 (22:12) / "PR Newswire"
Endoscopy Devices Market size is set to grow by USD 14.24 billion from 2024-2028, advances in endoscopy ... - PR Newswire
Endoscopy Devices Market size is set to grow by USD 14.24 billion from 2024-2028, advances in endoscopy ... PR ...
In Article Trend: Somewhat-Bullish
April 19, 2024 (13:15) / "Zacks Commentary" (by Zacks Equity Research)
Unveiling Boston Scientific ( BSX ) Q1 Outlook: Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Boston Scientific (BSX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
In Article Trend: Neutral
April 18, 2024 (15:09) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Retain Medtronic ( MDT ) Stock for Now
Investors continue to be optimistic about Medtronic (MDT) due to the strength of its Neurosurgery and Cardiovascular portfolios.
In Article Trend: Somewhat-Bullish
April 18, 2024 (14:02) / "Benzinga" (by Vandana Singh)
FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious' - Boston Scientific ( NYSE:BSX )
On Wednesday, Boston Scientific Corporation BSX said it recalled Obsidio Embolic by issuing a correction. The FDA has identified this as a Class I recall, the most severe type of recall.
In Article Trend: Neutral
April 18, 2024 (07:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)
Establishment Labs Hldgs Shows Rising Price Performance With Jump To 84 RS Rating
On Thursday, Establishment Labs Hldgs ( ESTA ) received an upgrade to its Relative Strength ( RS ) Rating, from 80 to 84. X IBD's proprietary RS Rating identifies technical performance by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our ...
In Article Trend: Somewhat-Bullish
April 18, 2024 (07:00) / "Investors Business Daily" (by Investor's Business Daily)
Stocks Flashing Renewed Technical Strength: Inspire Medical Systems
Inspire Medical Systems ( INSP ) had its Relative Strength ( RS ) Rating upgraded from 67 to 84 Thursday. X This unique rating tracks technical performance by using a 1 ( worst ) to 99 ( best ) score that indicates how a stock's price performance over the trailing 52 weeks matches up against ...
In Article Trend: Bullish
April 17, 2024 (07:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)
Boston Scientific Joins Elite List Of Stocks With 95-Plus Composite Rating
On Wednesday, Boston Scientific ( BSX ) got an upgrade for its IBD SmartSelect Composite Rating from 94 to 96. X The revised score means the stock currently tops 96% of all other stocks in terms of key performance metrics and technical strength.
In Article Trend: Somewhat-Bullish
April 16, 2024 (19:30) / "Benzinga" (by Benzinga Insights)
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years - Boston Scientific ( NYSE:BSX )
Boston Scientific BSX has outperformed the market over the past 10 years by 7.04% on an annualized basis producing an average annual return of 17.43%. Currently, Boston Scientific has a market capitalization of $100.81 billion.
In Article Trend: Somewhat-Bullish
April 16, 2024 (14:44) / "Zacks Commentary" (by Zacks Equity Research)
What's in Store for Boston Scientific ( BSX ) in Q1 Earnings?
Boston Scientific (BSX) is expected to have registered strong growth in the Asia Pacific, led by strength in China, Japan and Latin America.
In Article Trend: Bullish
April 16, 2024 (13:00) / "PR Newswire"
Ascential Medical & Life Sciences Appoints Anupam Girdhar as Divisional CEO - PR Newswire
Ascential Medical & Life Sciences Appoints Anupam Girdhar as Divisional CEO PR ...
In Article Trend: Somewhat-Bullish
April 16, 2024 (08:34) / "Zacks Commentary" (by Zacks Investment Research)
Zacks Industry Outlook Highlights Edwards Lifesciences, DexCom and STERIS
Edwards Lifesciences, DexCom and STERIS have been highlighted in this Industry Outlook article.
In Article Trend: Neutral
April 15, 2024 (18:42) / "Benzinga" (by Vandana Singh)
Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA Why Is Medical Device Manufacture Integer Stock Gaining Today? - Integer Holdings ( NYSE:ITGR )
BofA Securities upgraded Integer Holdings Corporation ITGR, citing the anticipated growth in pulsed field ablation ( PFA ) for treating atrial fibrillation. Integer is one of the largest medical device outsourcing manufacturers, serving the cardiac rhythm management, neuromodulation, ...
In Article Trend: Somewhat-Bullish
April 15, 2024 (15:16) / "Zacks Commentary" (by Urmimala Biswas)
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
The Zacks Medical - Instruments industry is expected to gain from the rising adoption of smart healthcare options, including genAI. However, supply issues and staffing shortages continue to disrupt growth. EW, DXCM and STE appear well-poised to brave the challenges.
In Article Trend: Neutral
April 11, 2024 (14:02) / "Benzinga" (by Gary Brode)
5 Things To Know In Investing This Week - The Shockwave Takeover Issue - Johnson & Johnson ( NYSE:JNJ ) , Shockwave Medical ( NASDAQ:SWAV )
The Shockwave offer that DKI predicted in December happened this week with Johnson & Johnson JNJagreeing to pay $335 per share in cash. DKI subscribers celebrated! The PMI came in hot. Don't want to read the details? The conclusion is "higher for longer".
In Article Trend: Neutral
April 11, 2024 (13:31) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic's ( MDT ) Sphere-360 PFA Study Outcome Favorable
Medtronic's (MDT) Sphere-360 catheter is designed to simplify the atrial fibrillation process while increasing efficiency and giving long-lasting lesions.
In Article Trend: Somewhat-Bullish
April 11, 2024 (10:45) / "Benzinga" (by Zacks)
Boston Scientific ( BSX ) Faces Rising Costs, Competition - Boston Scientific ( NYSE:BSX ) , Cardinal Health ( NYSE:CAH )
Boston Scientific Corporation BSX has been struggling due to unfavorable currency movement and macroeconomic woes. Strong competitors in the large medical device market also pose a tough challenge for Boston Scientific. The stock carries a Zacks Rank #4 ( Sell ) currently.
In Article Trend: Neutral
April 11, 2024 (07:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)
Stocks Showing Market Leadership: TransMedics Group Earns 92 RS Rating
On Thursday, TransMedics Group ( TMDX ) hit an important performance benchmark, seeing its Relative Strength ( RS ) Rating jump into the 90-plus percentile with an improvement to 92, up from 87 the day before.
In Article Trend: Bullish
April 11, 2024 (07:00) / "Investors Business Daily" (by Investor's Business Daily)
Inspire Medical Systems Sees IBD RS Rating Climb To 76
Inspire Medical Systems ( INSP ) saw a positive improvement to its Relative Strength ( RS ) Rating on Thursday, rising from 65 to 76. X This unique rating measures technical performance by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our ...
In Article Trend: Bullish
April 11, 2024 (07:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)
IBD Rating Upgrades: LivaNova Flashes Improved Technical Strength
LivaNova ( LIVN ) had its Relative Strength ( RS ) Rating upgraded from 67 to 73 Thursday - a welcome improvement, but still shy of the 80 or better score you look for.
In Article Trend: Bullish
April 10, 2024 (13:30) / "Zacks Commentary" (by Zacks Equity Research)
Boston Scientific ( BSX ) Faces Rising Costs, Competition
With Boston Scientific (BSX) recording 40% of its sales from the international market, it remains highly exposed to currency fluctuations.
In Article Trend: Neutral
April 10, 2024 (10:00) / "Benzinga" (by Globe Newswire)
Medicines360 Appoints Erica Rogers to Board of Directors
SAN FRANCISCO, April 10, 2024 ( GLOBE NEWSWIRE ) -- Medicines360, a global mission-driven women's health company that focuses on developing new products and accelerating access to innovation for women, has appointed Erica Rogers to the Board of Directors, effective March 8, 2024.
In Article Trend: Somewhat-Bullish
April 8, 2024 (15:40) / "Zacks Commentary" (by Zacks Equity Research)
AHCO or BSX: Which Is the Better Value Stock Right Now?
AHCO vs. BSX: Which Stock Is the Better Value Option?
In Article Trend: Bullish
April 8, 2024 (07:00) / "Investors Business Daily" (by Investor's Business Daily)
Stocks With Rising Relative Price Strength: TransMedics Group
TransMedics Group ( TMDX ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Monday, rising from 64 to 83. X IBD's unique RS Rating tracks market leadership by showing how a stock's price action over the last 52 weeks measures up against that of other stocks on the major ...
In Article Trend: Bullish
April 8, 2024 (04:00) / "PR Newswire" (by Boston Scientific Corporation)
Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and FARAVIEW™ Software Module
Boston Scientific Initiates NAVIGATE-PF Study of the FARAWAVE™ Nav Pulsed Field Ablation Catheter and ... PR ...
In Article Trend: Neutral
April 3, 2024 (14:23) / "Benzinga" (by Gary Brode)
5 Things to Know in Investing This Week - Boston Scientific ( NYSE:BSX ) , Johnson & Johnson ( NYSE:JNJ )
The Personal Consumption Expenditures ( PCE ) Index is the preferred inflation metric for the Federal Reserve. This month's report came out during Good Friday when the markets are closed. Within hours, the hawks who favor higher rates and the doves who favor lower rates all claimed the report ...
In Article Trend: Neutral
April 3, 2024 (14:00) / "Benzinga" (by Globe Newswire)
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm - iRhythm Technologies ( NASDAQ:IRTC )
NEW YORK, April 03, 2024 ( GLOBE NEWSWIRE ) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against iRhythm Technologies, Inc. ( "iRhythm" or the "Company" ) IRTC and reminds investors of the April 8, 2024 deadline to seek the role of lead ...
In Article Trend: Neutral
April 3, 2024 (04:00) / "PR Newswire"
Great Place To Work unveils Top 10 Best Workplaces in Singapore Healthcare and Biopharma™ 2024 - PR Newswire
Great Place To Work unveils Top 10 Best Workplaces in Singapore Healthcare and Biopharma™ 2024 PR ...
In Article Trend: Bullish
April 2, 2024 (14:15) / "Benzinga" (by Benzinga Insights)
Looking Into Boston Scientific's Recent Short Interest - Boston Scientific ( NYSE:BSX )
Boston Scientific's BSX short percent of float has risen 21.88% since its last report. The company recently reported that it has 11.48 million shares sold short, which is 0.78% of all regular shares that are available for trading.
In Article Trend: Somewhat-Bullish
April 2, 2024 (12:30) / "Benzinga" (by Globe Newswire)
Electroceuticals/Bioelectric Medicine Market is Expected to Reach $33.6 billion | MarketsandMarkets™
Chicago, April 02, 2024 ( GLOBE NEWSWIRE ) -- Electroceuticals/Bioelectric Medicine market in terms of revenue was estimated to be worth $23.9 billion in 2024 and is poised to reach $33.6 billion by 2029, growing at a CAGR of 7.0% from 2024 to 2029 according to a latest report published by ...
In Article Trend: Somewhat-Bullish
March 31, 2024 (14:27) / "Business Insider" (by NEWSFILE)
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In iRhythm To Contact Him Directly To Discuss Their Options
In Article Trend: Neutral
March 29, 2024 (15:30) / "PR Newswire"
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm - PR Newswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm PR ...
In Article Trend: Neutral
March 29, 2024 (10:01) / "South China Morning Post" (by Daniel Ren)
Shanghai's US$13.8 billion fund of funds to boost AI, semiconductor firms
Mainland China's commercial and financial hub plans to set up a 100 billion yuan (US$13.8 billion) fund of funds focusing on key technology sectors to fire up the local economy.
In Article Trend: Somewhat-Bullish
March 28, 2024 (18:30) / "Benzinga" (by Benzinga Insights)
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $8,100 Today - Boston Scientific ( NYSE:BSX )
Boston Scientific BSX has outperformed the market over the past 15 years by 2.08% on an annualized basis producing an average annual return of 15.03%. Currently, Boston Scientific has a market capitalization of $100.86 billion.
In Article Trend: Somewhat-Bullish
March 28, 2024 (15:17) / "Zacks Commentary" (by Zacks Investment Research)
C3.ai ( AI ) , Paradyme Extend Partnership to Deliver AI Solutions
C3.ai (AI) expands partnership agreement with Paradyme that aims at accelerating the delivery of AI solutions tailored for the U.S. Intelligence Community.
In Article Trend: Somewhat-Bullish
March 28, 2024 (14:55) / "Benzinga" (by Globe Newswire)
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm - iRhythm Technologies ( NASDAQ:IRTC )
NEW YORK, March 28, 2024 ( GLOBE NEWSWIRE ) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against iRhythm Technologies, Inc. ( "iRhythm" or the "Company" ) IRTC and reminds investors of the April 8, 2024 deadline to seek the role of lead ...
In Article Trend: Neutral
March 28, 2024 (14:02) / "Zacks Commentary" (by Zacks Equity Research)
Shockwave Medical ( SWAV ) Up on Potential Acquisition Rumors
Shockwave Medical's (SWAV) shares gain as rumors about its potential acquisition by an industry giant get media attention.
In Article Trend: Somewhat-Bullish
March 28, 2024 (12:03) / "Zacks Commentary" (by Zacks Equity Research)
Boston Scientific ( BSX ) and Scivita Medical Expand Partnership
Boston Scientific (BSX) and Scivita Medical announce an expanded strategic cooperation arrangement.
In Article Trend: Somewhat-Bullish
March 28, 2024 (08:00) / "Investors Business Daily" (by Investor's Business Daily)
Tandem Diabetes Care Shows Rising Price Performance With Jump To 85 RS Rating
Tandem Diabetes Care ( TNDM ) saw a positive improvement to its Relative Strength ( RS ) Rating on Thursday, with an increase from 78 to 85. X This exclusive rating from Investor's Business Daily tracks price action with a 1 ( worst ) to 99 ( best ) score.
In Article Trend: Bullish
March 27, 2024 (20:23) / "Benzinga" (by Vandana Singh)
Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst - Boston Scientific ( NYSE:BSX ) , Johnson & Johnson ( NYSE:JNJ ) , Medtronic ( NYSE:MDT ) , Shockwave Medical ( NASDAQ:SWAV )
Tuesday, Shockwave Medical Inc SWAV shares traded higher following a Wall Street Journal report suggesting Johnson & Johnson JNJ is reportedly in talks to acquire the company. Shockwave Medical is a cardiovascular medical device.
In Article Trend: Somewhat-Bullish
March 26, 2024 (21:30) / "PR Newswire" (by Inc.)
AZZ Inc. Announces CFO Succession Plan
FORT WORTH, Texas, March 26, 2024 /PRNewswire/ -- AZZ Inc. ( NYSE: AZZ ) , the leading independent provider of hot-dip galvanizing and coil coating solutions in North America, today announced that Mr. Philip Schlom, Chief Financial Officer of AZZ, will retire from the Company upon completion of ...
In Article Trend: Neutral
March 26, 2024 (01:30) / "Canada Newswire"
Scivita Medical Expands Collaboration with Boston Scientific - Canada NewsWire
Scivita Medical Expands Collaboration with Boston Scientific Canada ...
In Article Trend: Bullish
March 26, 2024 (01:30) / "Benzinga" (by PRNewswire)
Scivita Medical Expands Collaboration with Boston Scientific - Boston Scientific ( NYSE:BSX )
SUZHOU, China, March 25, 2024 /CNW/ -- Recently, Scivita Medical Technology Co., Ltd. ( "Scivita Medical" ) and Boston Scientific Corporation BSX, a leading global medical technology company, joined hands again to sign an expanded strategic cooperation arrangement.
In Article Trend: Bullish
March 26, 2024 (01:30) / "Benzinga" (by PRNewswire)
Scivita Medical Expands Collaboration with Boston Scientific - Boston Scientific ( NYSE:BSX )
SUZHOU, China, March 25, 2024 /PRNewswire/ -- Recently, Scivita Medical Technology Co., Ltd. ( "Scivita Medical" ) and Boston Scientific Corporation BSX, a leading global medical technology company, joined hands again to sign an expanded strategic cooperation arrangement.
In Article Trend: Bullish
March 25, 2024 (15:03) / "Benzinga" (by Globe Newswire)
Occupancy Analytics Firm Hosting Virtual Panel on Women's Leadership in Real Estate Space Planning
BOSTON, March 25, 2024 ( GLOBE NEWSWIRE ) -- Occupancy analytics software company Lambent will host a virtual panel on the role of women in real estate space planning on March 28th.
In Article Trend: Somewhat-Bullish
March 22, 2024 (15:40) / "Zacks Commentary" (by Zacks Equity Research)
AHCO vs. BSX: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Products sector might want to consider either AdaptHealth Corp. ( AHCO Quick QuoteAHCO - ) or Boston Scientific ( BSX Quick QuoteBSX - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find ...
In Article Trend: Bullish
March 22, 2024 (15:27) / "Benzinga" (by Chris Katje)
's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet - Bank of America ( NYSE:BAC ) , Boston Scientific ( NYSE:BSX )
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention. Investors are constantly on the hunt for undervalued, under-followed and emerging stocks.
In Article Trend: Somewhat-Bullish
March 22, 2024 (08:16) / "Motley Fool" (by John Ballard)
2 AI Stocks to Buy Hand Over Fist in March
These growth stocks could power your savings over the next 10 years.
In Article Trend: Bullish
March 21, 2024 (14:55) / "Benzinga" (by Zacks)
4 Fidelity Mutual Funds to Buy as Volatility Continues - C3.ai ( NYSE:AI )
Fidelity Investments, one of the largest asset managers in the world, was founded in 1946 and is currently headquartered in Boston, MA. Proven efficiency in fund management and the ability to survive market volatility have enhanced the company's reputation over the years.
In Article Trend: Somewhat-Bullish
March 19, 2024 (15:40) / "Benzinga" (by Globe Newswire)
Cardiovascular Implants Market Poised For Strong Growth, Reaching $34.5 Billion In 2028: Latest Report Unveils Insights As Per The Business Research Company's Cardiovascular Implants Global Market Report 2024
LONDON, March 19, 2024 ( GLOBE NEWSWIRE ) -- The global cardiovascular implants market is experiencing robust growth, as highlighted in the newest report "Cardiovascular Implants Market Global Report 2024", by The Business Research Company.
In Article Trend: Bullish
March 19, 2024 (09:34) / "Zacks Commentary" (by Zacks Equity Research)
4 Fidelity Mutual Funds to Buy as Volatility Continues
Invest in Fidelity mutual funds like FPHAX, FDCAX, FMAGX and FDSCX for high returns alongside risk reduction in the current environment.
In Article Trend: Somewhat-Bullish
March 18, 2024 (17:00) / "GlobeNewswire" (by Genius Group Limited)
Genius Group and OpenExO Sign Merger Agreement, Accelerating Plans to Build Global AI Education Group
SINGAPORE, March 18, 2024 ( GLOBE NEWSWIRE ) -- Genius Group Limited ( NYSE American: GNS ) ( "Genius Group" or the "Company" ) , a leading entrepreneur edtech and education group, and OpenExO ( "OpenExO" ) an AI-driven global community of 36,000 educators, entrepreneurs and enterprises building ...
In Article Trend: Somewhat-Bullish
March 18, 2024 (14:30) / "Benzinga" (by Globe Newswire)
Implantable Cardiac Monitor Market Predicted to Achieve 6.6% CAGR and Valued at USD 1.6 Billion by 2031- Report by Transparency Market Research, Inc.
Wilmington, Delaware, United States, March 18, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. -The implantable cardiac monitor industry was worth US$ 914.5 million in 2022. By the end of 2031, the market is expected to reach US$ 1.6 billion, advancing at a CAGR of 6.6% from 2023 to ...
In Article Trend: Somewhat-Bullish
March 18, 2024 (13:28) / "Zacks Commentary" (by Zacks Equity Research)
Boston Scientific ( BSX ) Global Growth Robust, Macro Issues Ail
Boston Scientific (BSX) is consistently registering fast recovery within its MedSurg segment in the post-pandemic period.
In Article Trend: Somewhat-Bullish
March 16, 2024 (06:19) / "Stocknews.com" (by Defense World Staff)
Boston Scientific ( NYSE:BSX ) Stock Rating Lowered by StockNews.com
Boston Scientific ( NYSE:BSX - Get Free Report ) was downgraded by equities researchers at StockNews.com from a "buy" rating to a "hold" rating in a research report issued on Saturday. Several other equities research analysts have also recently issued reports on the stock.
In Article Trend: Somewhat-Bullish
March 15, 2024 (22:48) / "PR Newswire"
Ultrasound Equipment Market to Grow by 2.98 billion by 2028, 5.76% YOY market growth recorded in 2023-2024 ... - PR Newswire
Ultrasound Equipment Market to Grow by 2.98 billion by 2028, 5.76% YOY market growth recorded in 2023-2024 ... PR ...
In Article Trend: Bullish
March 15, 2024 (16:33) / "Investors Business Daily" (by ALLISON GATLIN)
Why Abbott's Formula Selloff Could Be A Buying Opportunity, Says Analyst
Abbott Stock Dives As Fellow Formula Maker Fined $60 Million Following Infant Death Investor's Business Daily ...
In Article Trend: Neutral
March 15, 2024 (12:53) / "Zacks Commentary" (by Zacks Equity Research)
Axonics ( AXNX ) Gets CE Mark for Sacral Neuromodulation System
Axonics' (AXNX) fourth-generation rechargeable Sacral Neuromodulation system will reduce the frequency of patient recharges significantly. The new form factor ensures ease of use.
In Article Trend: Bullish
March 15, 2024 (01:00) / "Benzinga" (by Globe Newswire)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, and Amplitude and Encourages Investors to Contact the Firm - Amplitude ( NASDAQ:AMPL ) , Hut 8 ( NASDAQ:HUT )
NEW YORK, March 14, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of iRhythm Technologies, Inc. IRTC, Hut 8 Corp. HUT, and Amplitude, Inc.
In Article Trend: Neutral
March 14, 2024 (13:45) / "Zacks Commentary" (by Zacks Equity Research)
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
In Article Trend: Bullish
March 12, 2024 (12:03) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Retain Medtronic ( MDT ) Stock for Now
Investors continue to be optimistic about Medtronic (MDT) on the strength of the Neurosurgery and Cardiovascular and Neurosurgery portfolios.
In Article Trend: Somewhat-Bullish
March 11, 2024 (18:03) / "Investors Business Daily" (by JULIE MAK)
Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher
On Monday, Tandem Diabetes Care ( TNDM ) stock received an upgrade to its Relative Strength ( RS ) Rating, from 68 to 78. This unique rating tracks technical performance by using a 1 ( worst ) to 99 ( best ) score that identifies how a stock's price action over the trailing 52 weeks stacks up ...
In Article Trend: Somewhat-Bullish
March 11, 2024 (13:56) / "Forbes" (by Megan Poinski)
Lumen Technologies' CEO On Their People-First Reset
This is the published version of Forbes' CEO newsletter, which offers the latest news for today's and tomorrow's business leaders and decision makers. Click here to get it delivered to your inbox every Sunday. Admitting that you were wrong is difficult, but it's something leaders do.
In Article Trend: Neutral
March 11, 2024 (08:00) / "Investors Business Daily" (by Investor's Business Daily)
Stocks With Rising Relative Strength: Baxter International
Baxter International ( BAX ) saw a welcome improvement to its Relative Strength ( RS ) Rating on Monday, rising from 70 to 73. X This proprietary rating tracks technical performance by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in ...
In Article Trend: Bullish
March 11, 2024 (08:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)
Tandem Diabetes Care Trying To Close In On Key Technical Benchmark
On Monday, Tandem Diabetes Care ( TNDM ) received an upgrade to its Relative Strength ( RS ) Rating, from 68 to 78. X This unique rating tracks technical performance by using a 1 ( worst ) to 99 ( best ) score that identifies how a stock's price action over the trailing 52 weeks stacks up ...
In Article Trend: Somewhat-Bullish
March 11, 2024 (03:30) / "Benzinga" (by Globe Newswire)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, and Amplitude and Encourages Investors to Contact the Firm - Amplitude ( NASDAQ:AMPL ) , Hut 8 ( NASDAQ:HUT )
NEW YORK, March 10, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of iRhythm Technologies, Inc. IRTC, Hut 8 Corp. HUT, and Amplitude, Inc.
In Article Trend: Neutral
March 10, 2024 (07:46) / "Stocknews.com" (by Defense World Staff)
Boston Scientific ( NYSE:BSX ) Upgraded to "Buy" by StockNews.com
Boston Scientific ( NYSE:BSX - Get Free Report ) was upgraded by equities research analysts at StockNews.com from a "hold" rating to a "buy" rating in a research note issued on Friday. BSX has been the subject of a number of other research reports.
In Article Trend: Somewhat-Bullish
March 8, 2024 (16:30) / "Zacks Commentary" (by Zacks Equity Research)
Envista ( NVST ) Down 5.8% Since Last Earnings Report: Can It Rebound?
Envista (NVST) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Neutral
March 8, 2024 (16:00) / "Benzinga" (by Benzinga Insights)
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,200 Today - Boston Scientific ( NYSE:BSX )
Boston Scientific BSX has outperformed the market over the past 10 years by 7.33% on an annualized basis producing an average annual return of 18.15%. Currently, Boston Scientific has a market capitalization of $99.32 billion.
In Article Trend: Somewhat-Bullish
March 8, 2024 (15:30) / "Zacks Commentary" (by Zacks Equity Research)
Envista ( NVST ) Down 5.8% Since Last Earnings Report: Can It Rebound?
Envista (NVST) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Neutral
March 8, 2024 (08:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)
Stocks To Watch: Edwards Lifesciences Sees RS Rating Jump To 87
Edwards Lifesciences ( EW ) saw a positive improvement to its Relative Strength ( RS ) Rating on Friday, with an upgrade from 80 to 87. X This exclusive rating from Investor's Business Daily tracks market leadership with a 1 ( worst ) to 99 ( best ) score.
In Article Trend: Bullish
March 8, 2024 (08:00) / "Investors Business Daily" (by Investor's Business Daily)
Align Technology Getting Closer To Key Technical Benchmark
In a welcome move, Align Technology ( ALGN ) saw its Relative Strength Rating improve from 68 to 73 on Friday. X IBD's unique RS Rating measures technical performance by using a 1 ( worst ) to 99 ( best ) score that shows how a stock's price action over the last 52 weeks matched up against all ...
In Article Trend: Somewhat-Bullish
March 7, 2024 (19:59) / "Forbes" (by Derek Saul)
S&P 500 Sets Another Record-And These Stocks Hit All-Time Highs
S&P 500 Hits Peak As These Stocks Set Records Forbes ...
In Article Trend: Somewhat-Bullish
March 7, 2024 (02:00) / "Benzinga" (by Globe Newswire)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, Xponential, and Amplitude and Encourages Investors to Contact the Firm - Amplitude ( NASDAQ:AMPL ) , Hut 8 ( NASDAQ:HUT )
NEW YORK, March 06, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of iRhythm Technologies, Inc. IRTC, Hut 8 Corp. HUT, Xponential Fitness, Inc.
In Article Trend: Neutral
March 6, 2024 (08:00) / "Investors Business Daily" (by Investor's Business Daily)
Stocks Showing Improved Relative Strength: Baxter International
Baxter International ( BAX ) had its Relative Strength ( RS ) Rating upgraded from 64 to 71 Wednesday - a welcome improvement, but still below the 80 or higher score you prefer to see. X This exclusive rating from Investor's Business Daily tracks price performance with a 1 ( worst ) to 99 ( ...
In Article Trend: Bullish
March 5, 2024 (13:20) / "MarketWatch" (by Ciara Linnane)
Novo Nordisk says Ozempic helped patients with Type 2 diabetes in one new way
The company is planning to file for regulatory approval of a label expansion for Ozempic in the U.S. and European Union in 2024.
In Article Trend: Neutral
March 5, 2024 (08:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)
LivaNova Scores Relative Strength Rating Upgrade; Hits Key Threshold
LivaNova Scores Relative Strength Rating Upgrade. Hits Key Threshold Investor's Business Daily ...
In Article Trend: Somewhat-Bullish
March 5, 2024 (08:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)
IBD Rating Upgrades: Enovis Shows Improved Technical Strength
Enovis ( ENOV ) saw a positive improvement to its Relative Strength ( RS ) Rating on Tuesday, rising from 69 to 75. X IBD's proprietary rating identifies market leadership with a 1 ( worst ) to 99 ( best ) score.
In Article Trend: Somewhat-Bullish
March 5, 2024 (08:00) / "Investors Business Daily" (by Investor's Business Daily)
IBD Rating Upgrades: TransMedics Group Flashes Improved Relative Price Strength
The Relative Strength ( RS ) Rating for TransMedics Group ( TMDX ) jumped into a higher percentile Tuesday, as it got a lift from 69 to 79. This unique rating tracks market leadership by using a 1 ( worst ) to 99 ( best ) score that shows how a stock's price action over the last 52 weeks ...
In Article Trend: Somewhat-Bullish
March 5, 2024 (08:00) / "Investors Business Daily" (by INVESTOR'S BUSINESS DAILY)
Establishment Labs Hldgs Earns Relative Strength Rating Upgrade; Hits Key Threshold
Establishment Labs Hldgs Earns Relative Strength Rating Upgrade. Hits Key Threshold Investor's Business Daily ...
In Article Trend: Somewhat-Bullish
March 4, 2024 (16:27) / "Zacks Commentary" (by Zacks Equity Research)
Boston Scientific ( BSX ) Grows IC Business With New FDA Nod
The AGENT DCB of Boston Scientific (BSX) is already available in Europe, parts of Asia Pacific and Latin America.
In Article Trend: Somewhat-Bullish
March 4, 2024 (13:05) / "Benzinga" (by Globe Newswire)
Global Urinary Incontinence Treatment Devices Market Size is Estimated to Reach USD 6.02 billion by 2030, Growing at a CAGR of 6.58%: Straits Research
New York, United States, March 04, 2024 ( GLOBE NEWSWIRE ) -- A medical disease called urinary incontinence causes uncontrollable urine loss. Medical devices are used to treat chronic urine incontinence and to grow and strengthen the pelvic floor muscles.
In Article Trend: Neutral
March 4, 2024 (10:06) / "Benzinga" (by Globe Newswire)
Gastrointestinal Bleeding Treatment Market Set to Reach USD 824.9 million by 2031, with a 5.4% CAGR Growth: Transparency Market Research, Inc.
Wilmington, Delaware, United States, March 04, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global gastrointestinal bleeding treatment market is projected to rise at a CAGR of 5.4% from 2023 to 2031.
In Article Trend: Somewhat-Bullish
March 4, 2024 (01:12) / "PR Newswire"
Enteral Feeding Devices Market size to grow by USD 1.36 billion from 2022-2027, North America to account for 46% of ... - PR Newswire
Enteral Feeding Devices Market size to grow by USD 1.36 billion from 2022-2027, North America to account for 46% of ... PR ...
In Article Trend: Somewhat-Bullish
March 3, 2024 (02:00) / "Benzinga" (by Globe Newswire)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm, Hut 8, Xponential, and Amplitude and Encourages Investors to Contact the Firm - Hut 8 ( NASDAQ:HUT ) , Amplitude ( NASDAQ:AMPL )
NEW YORK, March 02, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of iRhythm Technologies, Inc. IRTC, Hut 8 Corp. HUT, Xponential Fitness, Inc.
In Article Trend: Neutral
March 2, 2024 (12:20) / "Motley Fool" (by John Ballard)
C3.ai Stock Is Headed to $40, According to This Wall Street Analyst
The company beat analysts' estimates in its latest earnings report, citing "staggering" demand for enterprise AI.
In Article Trend: Bullish
March 2, 2024 (07:06) / "Stocknews.com" (by ABMN Staff)
Boston Scientific ( NYSE:BSX ) Lowered to "Hold" at StockNews.com
Boston Scientific ( NYSE:BSX ) Lowered to "Hold" at ...
In Article Trend: Somewhat-Bullish
March 2, 2024 (00:36) / "PR Newswire"
Neurostimulation Devices Market size to grow at a CAGR of 12.19% from 2022 to 2027, The rising prevalence of ... - PR Newswire
Neurostimulation Devices Market size to grow at a CAGR of 12.19% from 2022 to 2027, The rising prevalence of ... PR ...
In Article Trend: Bullish
March 1, 2024 (23:00) / "Benzinga" (by Globe Newswire)
IRHYTHM INVESTOR ALERT: Kirby McInerney LLP Notifies iRhythm Technologies, Inc. ( IRTC ) Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit - iRhythm Technologies ( NASDAQ:IRTC )
NEW YORK, March 01, 2024 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP reminds investors of the April 8, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed on behalf of those who acquired iRhythm Technologies, Inc. ( "iRhythm" or ...
In Article Trend: Neutral
March 1, 2024 (22:15) / "Benzinga" (by Globe Newswire)
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues Investigating the Merger - KAMN, JNPR, INBX, AXNX
NEW YORK, March 01, 2024 ( GLOBE NEWSWIRE ) -- Monteverde & Associates PC ( the "M&A Class Action Firm" ) , has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report.
In Article Trend: Somewhat-Bullish
March 1, 2024 (16:30) / "Zacks Commentary" (by Zacks Equity Research)
Why Is Boston Scientific ( BSX ) Up 2.1% Since Last Earnings Report?
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Somewhat-Bullish
March 1, 2024 (16:30) / "Benzinga" (by Globe Newswire)
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm - iRhythm Technologies ( NASDAQ:IRTC )
NEW YORK, March 01, 2024 ( GLOBE NEWSWIRE ) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against iRhythm Technologies, Inc. ( "iRhythm" or the "Company" ) IRTC and reminds investors of the April 8, 2024 deadline to seek the role of lead ...
In Article Trend: Neutral
March 1, 2024 (14:50) / "Zacks Commentary" (by Zacks Equity Research)
Why Boston Scientific ( BSX ) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
In Article Trend: Bullish
March 1, 2024 (11:55) / "PR Newswire" (by Boston Scientific Corporation)
Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon
First coronary drug-coated balloon in U.S. provides safe, effective alternative to treat coronary in-stent restenosis and reduce risk of reoccurrence MARLBOROUGH, Mass., March 1, 2024 /PRNewswire/ -- Boston Scientific Corporation ( NYSE: BSX ) today announced it has received U.S.
In Article Trend: Neutral
February 29, 2024 (22:22) / "Zacks Commentary" (by Shaun Pruitt)
C3.ai's ( AI ) Stock Is Soaring After Earnings But is it Time to Buy?
As one of the more promising artificial intelligence companies, let's see if it's time to buy C3.ai's (AI) stock after revenue and contract growth fuel its post-earnings rally.
In Article Trend: Somewhat-Bullish
February 29, 2024 (18:08) / "PR Newswire" (by Elanco Animal Health)
Elanco Animal Health is Executing on Plan to Deliver for Shareholders
Ancora Nominates Director Candidates Despite Elanco's Meaningful Operational Progress and Good Faith Engagement with the Investor
In Article Trend: Somewhat-Bullish
February 29, 2024 (16:30) / "Benzinga" (by Globe Newswire)
Retinal Vein Occlusion Market Overview 2024-2028: Projected Market Size, Leading Growth Factors, And Top Segments As Per The Business Research Company's Retinal Vein Occlusion Global Market Report 2024
LONDON, Feb. 29, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Retinal Vein Occlusion Global Market Report 2024, the retinal vein occlusion market has witnessed rapid expansion, soaring from $13.79 billion in 2023 to $15.43 billion in 2024, boasting a remarkable compound ...
In Article Trend: Bullish
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website